IDiyas

For the Inventor, By the Inventor

Sanbornton, NH, United States of America

Graham Johnson

USPTO Granted Patents = 52 

 

Average Co-Inventor Count = 5.6

ph-index = 13

Forward Citations = 347(Granted Patents)

Forward Citations (Not Self Cited) = 241(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Madison, CT (US) (1996 - 2017)
  • Sanbornton, NH (US) (2016 - 2024)

Company Filing History:

goldMedal18 out of 2,487 
 
Columbia University
 patents
silverMedal15 out of 3,681 
 
Bristol-myers Squibb Compnay
 patents
bronzeMedal5 out of 2,099 
 
University of Washington
 patents
4. 4 out of 289 
 
Fred Hutchinson Cancer Center
 patents
5. 4 out of 8 
 
Ariagen, Inc.
 patents
6. 4 out of 2,882 
 
The General Hospital Corporation
 patents
7. 3 out of 3,435 
 
National Institutes of Health, a Component of the US Dept. of Health & Human Services
 patents
8. 2 out of 3 
 
Eleusis Therapeutics Us, Inc.
 patents
9. 2 out of 2 
 
Oricula Therapeutics LLC
 patents
10. 2 out of 15,458 
 
University of California
 patents
11. 2 out of 23 
 
Melinta Therapeutics, Inc.
 patents
12. 1 out of 97 
 
Albany Molecular Research, Inc.
 patents
13. 1 out of 461 
 
Science Applications International Corporation
 patents
14. 1 out of 17 
 
Rib-x Pharmaceuticals, Inc.
 patents
where one patent can have more than one assignee

Years Active: 1996-2025

Loading Chart...
Loading Chart...
52 patents (USPTO):
1. 12473302 - 4-phenylpiperidines, their preparation and use (2025-11-18),
2. 12404277 - Substituted 4-phenylpiperidines, their preparation and use (2025-09-02),
3. 11919913 - 4-phenylpiperidines, their preparation and use (2024-03-05),
4. 11891386 - Indole compounds and their use (2024-02-06),
5. 11779573 - Crystalline forms of compounds for preventing or treating sensory hair cell death (2023-10-10),
6. 11702417 - Compounds for improving mRNA splicing (2023-07-18),
7. 11680043 - Pharmaceutically acceptable salts of psilocin and uses thereof (2023-06-20),
8. 11649240 - Substituted 4-phenylpiperidines, their preparation and use (2023-05-16),
9. 11459322 - Indole compounds and their use (2022-10-04),
10. 11427576 - Indole compounds and their use (2022-08-30),
11. 11390621 - Chiral indole compounds and their use (2022-07-19),
12. 11312684 - Pharmaceutically acceptable salts of psilocin and uses thereof (2022-04-26),
13. 11117884 - Potent gamma-secretase modulators (2021-09-14),
14. 11028098 - 4-phenylpiperidines, their preparation and use (2021-06-08),
15. 10913746 - Substituted 4-phenylpiperidines, their preparation and use (2021-02-09),

Title: Graham Johnson: Innovator in Pharmaceutical Compounds

Introduction

Graham Johnson, based in Sanbornton, NH, is an accomplished inventor with a remarkable portfolio that includes 50 patents. His innovative work in the pharmaceutical industry has contributed significantly to the development of new compounds and therapies.

Latest Patents

Among his recent patents are innovative compounds such as 4-phenylpiperidines, which focus on their preparation and utility. Additionally, he has developed relevant indole compounds along with pharmaceutical compositions that stimulate the immune system in patients, particularly in the context of cancer treatment. These advancements demonstrate his commitment to enhancing medical science through innovative solutions.

Career Highlights

Graham has had an impactful career at renowned institutions, including Bristol-Myers Squibb Company and Columbia University in the City of New York. His roles in these organizations allowed him to advance his research and push the boundaries of pharmaceutical innovation.

Collaborations

Throughout his career, Graham has collaborated with notable colleagues, including Konstantin Petrukhin and Christopher Cioffi. Their teamwork has fostered a collaborative environment that drives forward-thinking research and development in the pharmaceutical domain.

Conclusion

Graham Johnson exemplifies the spirit of innovation in the pharmaceutical industry. His extensive patent portfolio and collaborative efforts highlight not only his contributions but also his dedication to improving health outcomes through science and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…